Krystal Biotech (KRYS) Current Assets (2021 - 2025)
Historic Current Assets for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $1.0 billion.
- Krystal Biotech's Current Assets rose 3807.81% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 3807.81%. This contributed to the annual value of $1.0 billion for FY2025, which is 3807.81% up from last year.
- According to the latest figures from Q4 2025, Krystal Biotech's Current Assets is $1.0 billion, which was up 3807.81% from $925.6 million recorded in Q3 2025.
- In the past 5 years, Krystal Biotech's Current Assets ranged from a high of $1.0 billion in Q4 2025 and a low of $345.8 million during Q3 2021
- In the last 5 years, Krystal Biotech's Current Assets had a median value of $533.1 million in 2023 and averaged $576.0 million.
- As far as peak fluctuations go, Krystal Biotech's Current Assets tumbled by 1885.15% in 2023, and later surged by 6944.26% in 2024.
- Krystal Biotech's Current Assets (Quarter) stood at $442.3 million in 2021, then fell by 13.22% to $383.8 million in 2022, then skyrocketed by 53.19% to $587.9 million in 2023, then grew by 26.22% to $742.0 million in 2024, then soared by 38.08% to $1.0 billion in 2025.
- Its Current Assets stands at $1.0 billion for Q4 2025, versus $925.6 million for Q3 2025 and $841.3 million for Q2 2025.